280 related articles for article (PubMed ID: 35605956)
1. Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo.
Fu L; Shi B; Wen S; Morsch M; Wang G; Zhou Z; Mi C; Sadraeian M; Lin G; Lu Y; Jin D; Chung R
Acta Biomater; 2022 Jul; 147():403-413. PubMed ID: 35605956
[TBL] [Abstract][Full Text] [Related]
2. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
Fu L; Chung R; Shi B
Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
[TBL] [Abstract][Full Text] [Related]
3. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
4. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
5. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.
Tian XH; Wei F; Wang TX; Wang P; Lin XN; Wang J; Wang D; Ren L
Int J Nanomedicine; 2012; 7():1031-41. PubMed ID: 22403486
[TBL] [Abstract][Full Text] [Related]
7. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
Wang C; Cheng L; Liu Z
Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
10. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Abbott NJ; Begley DJ
J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
[TBL] [Abstract][Full Text] [Related]
12. Transport of drugs across the blood-brain barrier by nanoparticles.
Wohlfart S; Gelperina S; Kreuter J
J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
[TBL] [Abstract][Full Text] [Related]
13. A versatile upconversion surface evaluation platform for bio-nano surface selection for the nervous system.
Fu L; Morsch M; Shi B; Wang G; Lee A; Radford R; Lu Y; Jin D; Chung R
Nanoscale; 2017 Sep; 9(36):13683-13692. PubMed ID: 28876356
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.
Hu X; Yang F; Liao Y; Li L; Zhang L
Drug Deliv; 2017 Nov; 24(1):121-132. PubMed ID: 28156159
[TBL] [Abstract][Full Text] [Related]
15. Folic Acid-Conjugated Brush Polymers Show Enhanced Blood-Brain Barrier Crossing in Static and Dynamic
Mazrad ZAI; Refaat A; Morrow JP; Voelcker NH; Nicolazzo JA; Leiske MN; Kempe K
ACS Biomater Sci Eng; 2024 May; 10(5):2894-2910. PubMed ID: 38556768
[TBL] [Abstract][Full Text] [Related]
16. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
17. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
18. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability.
Rabanel JM; Piec PA; Landri S; Patten SA; Ramassamy C
J Control Release; 2020 Dec; 328():679-695. PubMed ID: 32979453
[TBL] [Abstract][Full Text] [Related]
19. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
Kulkarni SA; Feng SS
Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
[TBL] [Abstract][Full Text] [Related]
20. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
